Mikael Dolsten

CIK 1437590 · President R&D · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.21M

Companies

6

Total Filings

116

Lifetime Open-Market Net

-$31.70M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
A Director 5,548 $129.84 $720.4K -$606.2K 8 2026-06-02
Apellis Pharmaceuticals, Inc. (APLS) Delisted Director 0 $41.03 $0 $0 2 2026-05-14
RCKTW Director 44,220 $0.01 $429 $0 3 2025-07-18
PFE President R&D 323,710 $26.21 $8.48M -$31.09M 93 2024-09-16
KPTI Director $9.50 $0 8 2021-05-21
WYETH (WYEp) Delisted Sr. VP & Pres., Wyeth Research $0 1 2008-06-18

Recent Filings · Page 6 of 12

116 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-06-16 KPTI Grant (A) $0 EDGAR
2017-03-03 PFE Sell (S) −30,970 -$1.07M EDGAR
2017-03-01 PFE Mixed −60,027 -$3.15M EDGAR
2017-02-27 PFE Mixed +58,847 -$676.0K EDGAR
2016-11-16 PFE Disc (I) $0 EDGAR
2016-06-17 KPTI Grant (A) $0 EDGAR
2016-05-05 PFE Sell (S) −67,588 -$2.26M EDGAR
2016-03-01 PFE Mixed +8,981 -$288.7K EDGAR
2016-02-26 PFE Mixed +58,607 -$544.2K EDGAR
2015-05-26 KPTI Grant (A) $0 EDGAR
Showing 5160 of 116
Page 6 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.